Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Outcome in High Risk of Kidney Failure in Heart Failure Patients With and Without Tolvaptan
TCTR20220701005Phase 3Unknown
- Sponsor
- Navamindradhiraj University Research Fund
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in heart failure (HF), chronic kidney disease (CKD), kidney failure, sponsored by Navamindradhiraj University Research Fund. Status: unknown.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)chronic kidney disease (CKD)kidney failure
Beyond the preview
Go deeper on TCTR20220701005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220701005.